OConnell Daniel Joseph 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
OConnell Daniel Joseph
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-01-19$3.47/sh−15,200$52,753→ 502,485 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.3950 to $3.6500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.